Compare
Quantum X Labs Inc. vs Youxin Technology Ltd vs Firefly Neuroscience, Inc. vs T Stamp Inc
| Latest fiscal year | Quantum X Labs Inc. QXL | Youxin Technology Ltd YAAS | Firefly Neuroscience, Inc. AIFF | T Stamp Inc IDAI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-09-30 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $539.5K | $1.14M | $3.14M |
| Revenue growth (YoY) | n/a | +3.5% | +957.4% | +1.9% |
| Gross margin | n/a | 33.4% | 56.5% | n/a |
| Operating margin | n/a | -529.3% | -775.5% | -244.0% |
| Net margin | n/a | n/m | n/m | -265.2% |
| Net income | -$19.29M | -$9.65M | -$19.88M | -$8.33M |
| EPS (Diluted) | $2.28 | -$1.04 | n/a | -$2.67 |
| Operating cash flow | -$2.77M | -$3.91M | -$8.19M | -$5.69M |
| Free cash flow | n/a | n/a | n/a | -$5.73M |
| Cash & equivalents | $1.02M | $9.91M | n/a | $6.04M |
| Total assets | $10.76M | $10.78M | $10.48M | $11.24M |
| Total liabilities | n/a | $2.59M | $2.84M | $2.35M |
| Shareholders' equity | $4.99M | $8.19M | $7.64M | $8.89M |
| Return on year-end equity | -386.6% | -117.8% | -260.3% | -93.7% |
| Shares outstanding | 10.67M | n/a | 13.96M | 5.25M |
Revenue, most recent five fiscal years
| Fiscal year | Quantum X Labs Inc. | Youxin Technology Ltd | Firefly Neuroscience, Inc. | T Stamp Inc |
|---|---|---|---|---|
| Latest | $26.94M Ended 2024-12-31 | $539.5K Ended 2025-09-30 | $1.14M Ended 2025-12-31 | $3.14M Ended 2025-12-31 |
| 1 year earlier | $79.61M Ended 2023-12-31 | $521.2K Ended 2024-09-30 | $108.0K Ended 2024-12-31 | $3.08M Ended 2024-12-31 |
| 2 years earlier | $96.60M Ended 2022-12-31 | $896.0K Ended 2023-09-30 | $498.0K Ended 2023-12-31 | $4.56M Ended 2023-12-31 |
| 3 years earlier | $45.22M Ended 2021-12-31 | $1.28M Ended 2022-09-30 | $12.02M Ended 2022-12-31 | $5.39M Ended 2022-12-31 |
| 4 years earlier | $96.0K Ended 2020-12-31 | n/a | $15.03M Ended 2021-12-31 | $3.68M Ended 2021-12-31 |